633 related articles for article (PubMed ID: 17348700)
1. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
2. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
3. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
4. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
Ren G; Liu S; Liu H; Miao Z; Cheng Z
Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
[TBL] [Abstract][Full Text] [Related]
5. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
6. PET of malignant melanoma using 18F-labeled metallopeptides.
Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
9. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
10. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma.
Gao F; Sihver W; Jurischka C; Bergmann R; Haase-Kohn C; Mosch B; Steinbach J; Carta D; Bolzati C; Calderan A; Pietzsch J; Pietzsch HJ
Amino Acids; 2016 Mar; 48(3):833-847. PubMed ID: 26643502
[TBL] [Abstract][Full Text] [Related]
12. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
13. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
14. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
[TBL] [Abstract][Full Text] [Related]
15. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS
J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490
[TBL] [Abstract][Full Text] [Related]
16. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.
Raposinho PD; Correia JD; Alves S; Botelho MF; Santos AC; Santos I
Nucl Med Biol; 2008 Jan; 35(1):91-9. PubMed ID: 18158948
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
[TBL] [Abstract][Full Text] [Related]
18. Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.
Bapst JP; Calame M; Tanner H; Eberle AN
Bioconjug Chem; 2009 May; 20(5):984-93. PubMed ID: 19388674
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]